Scottish Renal Registry, Royal Infirmary, Glasgow, UK.
Perit Dial Int. 2011 Nov-Dec;31(6):639-50. doi: 10.3747/pdi.2010.00185. Epub 2011 Jul 31.
Peritoneal dialysis (PD)-related peritonitis remains the leading cause of technique failure and a significant cause of morbidity among PD patients. Rates in the literature vary, reflecting differences in study design and in populations. The objective of the present study was to determine peritonitis incidence and outcomes in Scotland and to compare them with national guidelines.
All 10 adult renal units in Scotland prospectively collect data relating to peritonitis for all PD patients in Scotland. Complete audit data between 1 January 2000 and 31 December 2007 were analyzed for the study.
The 1918 peritonitis episodes in 38 106 PD treatment months yielded a national rate of 1 episode every 19.9 months. The UK Renal Association standard was met every year, but is not consistently improving. The median peritonitis-free survival was 526 days (95% confidence interval: 463 to 589 days). The spectrum of causative organisms reflected those in previous reports, with a culture-negative rate of 19.4%. Nationally, the cure rate was 74.6%, the refractory rate was 22.6%, and the death rate was 2.8%. Outcome varied by organism. Recurrences represented 9.3% of episodes, and technique failure occurred in 14.9%. The peritonitis rate was higher for continuous ambulatory PD patients than for automated PD patients (1 episode every 17.6 months vs 1 episode every 22.3 months, p < 0.001, relative risk: 1.27). There were significant differences between renal units.
This large national PD cohort met targets for peritonitis rates every year during the 8 years covered by the present report, but showed no consistent trend for improvement. Peritonitis remains the main cause of technique failure in Scotland. Peritonitis rates varied widely between the units, which suggests that we should look to the units and countries with lower peritonitis rates to see if we can adopt successful elements of their practice before resigning ourselves to our ongoing peritonitis burden.
腹膜透析(PD)相关腹膜炎仍然是技术失败的主要原因,也是 PD 患者发病率的重要原因。文献中的发生率各不相同,这反映了研究设计和人群的差异。本研究的目的是确定苏格兰 PD 患者的腹膜炎发生率和结局,并将其与国家指南进行比较。
苏格兰的所有 10 个成人肾脏单位前瞻性地收集苏格兰所有 PD 患者的腹膜炎相关数据。对 2000 年 1 月 1 日至 2007 年 12 月 31 日期间的完整审计数据进行了分析。
在 38106 个 PD 治疗月中,1918 例腹膜炎发作导致全国腹膜炎发生率为每 19.9 个月 1 例。每年都符合英国肾脏病协会的标准,但并未持续改善。腹膜炎无复发生存中位数为 526 天(95%置信区间:463-589 天)。致病微生物的种类反映了以前报告中的情况,培养阴性率为 19.4%。全国范围内,治愈率为 74.6%,难治率为 22.6%,死亡率为 2.8%。结局因病原体而异。复发占发作的 9.3%,技术失败占 14.9%。与自动化 PD 患者相比,持续非卧床 PD 患者的腹膜炎发生率更高(每 17.6 个月 1 例 vs 每 22.3 个月 1 例,p<0.001,相对风险:1.27)。各肾脏单位之间存在显著差异。
本研究中报告的 8 年期间,该大型全国性 PD 队列每年都达到了腹膜炎发生率的目标,但没有显示出持续改善的趋势。腹膜炎仍然是苏格兰 PD 技术失败的主要原因。各单位之间的腹膜炎发生率差异很大,这表明我们应该关注腹膜炎发生率较低的单位和国家,看看是否可以在接受持续腹膜炎负担之前,借鉴他们成功的实践经验。